HIV Viral Suppression among People Living with HIV on Antiretroviral Therapy in Haut-Katanga and Kinshasa Provinces of Democratic Republic of Congo.
Gulzar Hussain ShahLievain Maluentesa NkutaGina D EtheredgeKristie C WaterfieldOsaremhen IkhileRoger BeniElodie EngeteleAstrid MulengaPublished in: Healthcare (Basel, Switzerland) (2021)
The VL was >1000 copies/mL for 19% of PLHIV receiving ART, indicating that these CDC-funded clinics and programs in the Haut-Katanga and Kinshasa provinces of DRC have more work to do. Strategically designed innovations in services are desirable, with customized approaches targeting PLHIV who are younger, male, those LTFU, with HIV/TB co-infection, and those receiving care from urban clinics.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- primary care
- hiv infected patients
- hiv aids
- healthcare
- sars cov
- palliative care
- mycobacterium tuberculosis
- public health
- quality improvement
- hepatitis c virus
- cell cycle
- affordable care act
- men who have sex with men
- pain management
- cancer therapy